The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors - ScienceDirect
Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata | Actas Dermo-Sifiliográficas
A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink
JAK inhibitors and COVID-19 | Journal for ImmunoTherapy of Cancer
Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata | Actas Dermo-Sifiliográficas
JAK Inhibitors: Prospects in Connective Tissue Diseases | SpringerLink
Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases | SpringerLink
Frontiers | Emerging Topical and Systemic JAK Inhibitors in Dermatology
Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases | Journal of Medicinal Chemistry
A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink
Safety of Janus kinase (JAK) inhibitors in the short‐term treatment of atopic dermatitis - Wood - 2022 - International Journal of Dermatology - Wiley Online Library
Janus kinase 3 inhibitor - Wikipedia
A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future? - Liu - 2021 - Arthritis & Rheumatology - Wiley Online Library
Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot - Gastroenterology
JAK Inhibitor 瑞石生物医药有限公司
JAK阻害 | JAK Inhibition
The emerging safety profile of JAK inhibitors in rheumatic disease | Nature Reviews Rheumatology
Cells | Free Full-Text | Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19
Selective Janus kinase inhibitors come of age | Nature Reviews Rheumatology
After 25 years of drug development, do we know JAK? | RMD Open
User's guide to JAK inhibitors in inflammatory bowel disease - ScienceDirect
Overview of small molecule inhibitors targeting the p38 MAPK pathway... | Download Scientific Diagram
Current and future status of JAK inhibitors - The Lancet
Frontiers | Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies
Frontiers | Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists
